Page 2 - Larry Lipshultz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Utah-based Inherent Biosciences just announced a massive Series A raise to better the male reproductive health field.

Men's Health Illustration/Getty ImagesGetty Images If you’re one of the 30 million men in the United States experiencing erectile dysfunction (ED), you’ve probably heard of nitroglycerin gels. And you're probably wondering where to get them. Unlike the little blue pills—which often require hours to work and have to be taken on an empty stomach—topical nitroglycerin gels and creams are rubbed directly onto the penis and begin working within minutes. “Nitro gels make sense because they’re more powerful than pills and can be applied right to where you need them to work,” says New...

Inherent Biosciences Raises Seed Round, Adds Board Members and Clinical Advisors Funding will be used to clinically validate and launch the company's proprietary male infertility diagnostic News provided by Share this article Share this article SALT LAKE CITY, Feb. 17, 2021 /PRNewswire/ -- Inherent Biosciences today announced its initial capital raise led by Morning Star Foundation with additional participation from MedMountain Ventures, Kickstart Funds, Park City Angels, Rhythm VC and several angel investors. With the initial funding, Inherent will launch a male infertility diagnostic to gu...